The FDA Authorized a Booster Shot of the Pfizer-BioNTech COVID-19 Vaccine—But Not For Everyone
for certain people already vaccinated against COVID-19 but at high risk of infection, including those over age 65 and those who are more likely to get exposed to the disease, such as health care, frontline, emergency and transportation workers, among others. The booster authorization only applies to Pfizer-BioNTech’s COVID-19 vaccine.
The agency’s decision follows the advice of its advisory committee, which met on Sept. 17 to review data on Pfizer-BioNTech’s booster, andto authorize an additional dose for certain populations.
There are less robust data on people in younger age groups, since anyone in that category who has been vaccinated received their shots more recently than the elderly, who the FDA prioritized to receive the Pfizer-BioNTech vaccine first, after the agency authorized the two-dose shot in Dec. 2020. That’s why the advisory committee voted against recommending a booster for all vaccinated people, as Pfizer-BioNTech originally requested, and limited its recommendation to high-risk populations.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA authorizes Pfizer-BioNTech booster shot for elderly, people at high risk of severe Covid-19Pfizer-BioNTech booster shots are now authorized by the FDA for people 65 and older and for certain high-risk adult populations
Read more »
FDA OKs Pfizer's booster shot for older adults and people at high riskBREAKING: FDA authorizes Pfizer Covid booster for emergency use in American ages 65 and over, as well as those at high risk of exposure to the coronavirus or severe illness, according to a senior administration official.
Read more »
J&J says booster greatly improves COVID-19 vaccine efficacy as experts await FDA decisionJohnson & Johnson became the latest COVID-19 vaccine maker to offer an update on booster doses Tuesday, when it said data from a Phase 3 trial and the real...
Read more »
FDA Authorizes Pfizer COVID Vaccine Booster Shots For Americans 65 And OlderPfizer said a third shot would restore the effectiveness of its COVID-19 vaccine to about 95%.
Read more »
FDA authorizes booster dose of Pfizer's Covid-19 vaccine for people 65 and olderThe FDA granted emergency use authorization for a booster dose of Pfizer's Covid-19 vaccine in people 65 and older, people at high risk of severe disease and people whose jobs put them at risk of infection.
Read more »
The FDA Authorized Pfizer Booster Shots For Older People And Those At High RiskThe emergency authorization will allow a third dose of the Pfizer-BioNTech vaccine to be given to people over 65, healthcare workers, and others at high risk of severe COVID-19.
Read more »